Philadelphia law firm Berger Montague has played a lead

New Post Public Reply Private Reply Replies (1) Message Board
bellsandwhistles bellsandwhistles #17132
Philadelphia law firm Berger & Montague has played a lead role in some of the most notable and newsworthy cases in United States history. For example, we were a principal plaintiffs' counsel in the Drexel Burnham Lambert/Michael Milken securities and bankruptcy litigation, in which claimants recovered approximately $2 billion in the aftermath of the junk bond market collapse and the Drexel bankruptcy in the late 1980's.

In the 1990s, Berger & Montague was one of the principal trial counsel in the Exxon Valdez Oil Spill litigation. The jury awarded a record $5 billion verdict against Exxon, which the United States Supreme Court later reduced to $507.5 million.

Berger & Montague was also lead counsel in the School Asbestos Litigation , the first mass tort property damage class action certified in the United States on a national basis. A class of secondary and elementary schools recovered in excess of $300 million to defray their asbestos abatement costs.

America's worst nuclear incident was the near meltdown of a reactor at Three Mile Island , just 15 miles from Harrisburg, Pennsylvania. Berger & Montague was lead/liaison counsel in the ensuing litigation.

Over 40 Years of Representing Businesses in Significant Civil Antitrust Litigation

In many of the most significant civil antitrust cases in United States history, Berger & Montague served as lead, co-lead or trial counsel, including the State of Connecticut Tobacco Litigation ($3.6 billion settlement); In re Corrugated Container Antitrust Litigation (more than $366 million recovered); the Infant Formula case ($125 million recovery); and the Brand Name Prescription Drug price fixing case (more than $700 million settlement). In pharmaceutical antitrust litigation , Berger & Montague has played a leading role in cases involving delayed entry of generic or other rival drug competition, and has achieved more than $1 billion in such settlements over the last decade.

Over 40 Years of Representing Institutional and Private Investors in Significant Securities Fraud Litigation

Since its founding, Berger & Montague has been privileged to have been selected to represent many state government public institutional investors, including, for example, the state retirement funds of Pennsylvania, Connecticut, New Hampshire, New Jersey, Louisiana and Ohio. We are also regularly selected to represent the retirement funds of numerous cities and municipalities, for example, the City of Philadelphia.

Berger & Montague also represents numerous individual and private institutional investors. For example, the firm was co-lead counsel in the Melridge Securities Litigation ($88.2 million jury verdict); and lead counsel in numerous major class action securities cases, including Merrill Lynch ($475 million); Rite Aid ($334 million); Waste Management ($220 million); Sunbeam ($142 million); IKON ($111 million); Medaphis ($96 million); Fleming Companies ($94 million); Cigna ($93 million); Xcel Energy ($80 million); and Alcatel ($75 million).

Over 10 Years of Representing Whistleblowers Under the IRS. SEC, CFTC & Qui Tam / False Claims Acts

Our ten attorney Whistleblower/Qui Tam practice, one of the largest in the United States, has recovered over $1.1 billion for federal and state taxpayers. For more than a decade, we have successfully represented whistleblowers in matters involving healthcare fraud, defense contracting fraud, IRS fraud, securities fraud, and commodities fraud.
Privileged to Represent Holocaust Victims

In human rights litigation, Berger & Montauge, through our executive committee membership in the Holocaust Victim Assets Litigation, helped to achieve a $1.25 billion settlement with Switzerland's largest banks on behalf of victims of Nazi aggression whose deposits were not returned after the Second World War. Our firm also is proud to have played an instrumental role in bringing about a $4.37 billion settlement with German industry and government for the use of slave and forced labor during the Holocaust.

The above cases are just several examples of the notable and newsworthy cases in which Berger & Montague has played a major role. No less important are the scores of cases in which we have successfully protected the rights of our clients in matters that may not have been in the newspaper, but were nonetheless vitally important to our clients' interests. Every matter is equally important to us, and we will vigorously protect our clients' interests above all else.
'http://www.bergermontague.com/

SK3 Group Inc. (SKTO) Stock Research Links

SKTO Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Webull Faces Class Action Suit: Key Deadlines Loom

Updated Category News Views 72

The Clock is Ticking for Webull Investors If anyone's got a Webull stake, listen up! You’ve got a deadline that's staring you in the face: December 7, 2026. This is when you need to throw your hat in the ring to be a lead plaintiff in the Webull Corporation class action. We're talking securities fraud, folks, with allegations flying that would make your head spin....

Continue Reading
Historic Records Set at 2026 CNO Monumental Marathon

Updated Category News Views 587

Race to Remember: Monumental Breakthroughs In the chilly November air of Indianapolis, the 2026 CNO Financial Indianapolis Monumental Marathon wasn't just another tick on the calendar—this was a banner day for running. With record-breaking performances across every distance, we saw what happens when a community of athletes, sponsors, and volunteers hits a perfect...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 116

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading
Gildan's Crisis: Investors Face Losses Amid Lawsuit

Updated Category News Views 133

Gildan Investors, Brace Yourself Poor old Gildan Activewear finds itself in hot water again, with a class action lawsuit cropping up like an unexpected storm on farmers' day. Any traders remotely involved with NYSE:GIL should pay damn close attention, because with a December 14, 2026 deadline looming, it's crunch time. The Root of the Lawsuit The plot thickens here,...

Continue Reading
TCL's Display Future: AI Meets Screens at DTC 2026

Updated Category News Views 563

Exploring New Horizons in Display Technology There's something brewing in Wuhan: a conference that’s shaping up like a tech enthusiast’s dream. This year, it's all about the symbiosis of cutting-edge tech and dazzling visuals as TCL CSOT gears up to unveil advancements at the Global Display Tech-Ecosystem Conference (DTC) 2026. If you're wondering whether this event...

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 222

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading
JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 169

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
Cleaner Air in Bedroom May Stabilize Blood Sugar Levels

Updated Category News Views 251

Imagine a world where simply sleeping in cleaner air could affect your blood sugar. Seems far-fetched, I know. But that's where we're at with this new study out of NYU Langone Health. They're talking about using plain ol' portable air filters to help steady blood sugar levels for folks dealing with prediabetes. Turns out a cleaner bedroom might just hold the key to taming...

Continue Reading
Intelligent Communication Forum Eyes Global Ecosystem Shift

Updated Category News Views 424

China's Grand Vision for Intelligent Communication You know what they say about big ideas—they start in the most bustling of places. And here we are in Wuxi, a city's pulse pounding with ambition, hosting the 2026 China International Intelligent Communication Forum. Picture it: From November 8th to 10th, movers, shakers, and visionaries are scribbling new blueprints for...

Continue Reading
MWC26 Doha: Bridging Standards for MENA's Future

Updated Category News Views 337

MWC26 Doha Launches with a Connectivity Mission Forget corporate boardrooms; the real action this week is unfolding in Doha's bustling exhibition halls. Kicked off with the fanfare you'd expect from such a key event, MWC26 Doha has drawn a crowd that's got both tech geeks and policy wonks nodding with interest. This ain’t your average trade show: it’s the melting pot...

Continue Reading

Top 5 Most Recently Viewed Articles

Modern Weddings Embrace Authenticity and Personalization

Updated Category News Views 6

Weddings Shaping Up to Be About More Than Just 'I Do' Anyone who's been to a wedding lately knows the game's changed. Lily & Lime dropped some eye-opening insights on how couples are tossing out the old rulebook and making weddings about something much more real and raw. Forget the cookie-cutter hullabaloo—we're talking personalized celebrations now. Finally, some...

Continue Reading
Tutor Perini Corp Achieves Record Milestone with Stock Growth

Updated Category News Views 71

Tutor Perini Corporation made headlines with its stock reaching a 52-week high of $27.06 back in 2024, reflecting a staggering rise of 242.27% over the year. You know how it goes when a company like this gets hot in the construction sector—investors pile on, chasing that momentum. Strong Q2 Surge: Earnings Play or Just Hype? The second quarter brought a significant 10%...

Continue Reading
Understanding McGrath RentCorp's Position in the Market

Updated Category News Views 121

Understanding McGrath RentCorp's Current Market Position In today's market, McGrath RentCorp Inc. (NASDAQ: MGRC) stands at a price of $96.27, marking a slight increase of 0.40%. Despite this recent uptick, the stock has seen a decline of 12.14% in the last month and a more significant drop of 17.19% over the past year. Investors are keen to assess whether the stock is...

Continue Reading
Phoenix Motor Faces Nasdaq Compliance Challenges Amid Growth

Updated Category News Views 197

Phoenix Motor Inc. Receives Nasdaq Compliance Notification Phoenix Motor Inc. (NASDAQ:PEV), a dynamic player in the electric vehicle (EV) manufacturing sector, is facing compliance issues after receiving a delinquency notice from Nasdaq. This notification arises from the company's inability to submit its quarterly financial report on time, which is a violation of Nasdaq...

Continue Reading
Converge Technology Solutions Adjusts December Dividend Payment

Updated Category News Views 231

Adjusted Dividend Payment Schedule for Shareholders Converge Technology Solutions Corp. (CTS) has made an important announcement regarding its dividend payment schedule. Originally set for December 28, 2024, the company has moved the payment date one day earlier, to December 27, 2024. This decision was made to ensure that shareholders receive their payments ahead of the...

Continue Reading